502 related articles for article (PubMed ID: 6311898)
41. Defective B cell function in systemic lupus erythematosus.
Pelton BK; Denman AM
Clin Exp Immunol; 1982 Jun; 48(3):513-8. PubMed ID: 6981471
[TBL] [Abstract][Full Text] [Related]
42. Functional analysis of the defective T cell regulation of the antigen-specific PFC response in SLE patients: differentiation of suppressor precursor cells to suppressor effector cells.
Heijnen CJ; Pot KH; Kater L; Kluin-Nelemans HC; Uytdehaag F; Ballieux RE
Clin Exp Immunol; 1982 Feb; 47(2):359-67. PubMed ID: 6210474
[TBL] [Abstract][Full Text] [Related]
43. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
[TBL] [Abstract][Full Text] [Related]
44. Cellular mechanisms of restricted immunoglobulin formation in the human neonate.
Andersson U; Bird G; Britton S
Eur J Immunol; 1980 Nov; 10(11):888-94. PubMed ID: 6257525
[TBL] [Abstract][Full Text] [Related]
45. Production of a monoclonal antibody to a membrane antigen of human T-cell leukaemia virus (HTLV1/ATLV)-infected cell lines from a systemic lupus erythematosus (SLE) patient: serological analyses for HTLV1 infections in SLE patients.
Kurata A; Katamine S; Fukuda T; Mine M; Ikari N; Kanazawa H; Matsunaga M; Eguchi K; Nagataki S
Clin Exp Immunol; 1985 Oct; 62(1):65-74. PubMed ID: 2998659
[TBL] [Abstract][Full Text] [Related]
46. Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis.
Mitarnun W; Pradutkanchana J; Takao S; Saechan V; Suwiwat S; Ishida T
J Med Assoc Thai; 2002 May; 85(5):552-9. PubMed ID: 12188384
[TBL] [Abstract][Full Text] [Related]
47. Epstein-Barr virus and systemic lupus erythematosus.
James JA; Harley JB; Scofield RH
Curr Opin Rheumatol; 2006 Sep; 18(5):462-7. PubMed ID: 16896283
[TBL] [Abstract][Full Text] [Related]
48. Suppressor-cell antibody in systemic lupus erythematosus. Possible mechanism for suppressor-cell dysfunction.
Sagawa A; Abdou NI
J Clin Invest; 1979 Mar; 63(3):536-9. PubMed ID: 311787
[TBL] [Abstract][Full Text] [Related]
49. Role of stimulated neutrophils from patients with systemic lupus erythematosus in disturbed immunoreactivity, with special reference to increased oxygen intermediates generated by the neutrophils.
Niwa Y; Sakane T; Shingu M; Yokoyama M
J Clin Lab Immunol; 1984 May; 14(1):35-43. PubMed ID: 6086929
[TBL] [Abstract][Full Text] [Related]
50. Epstein-Barr virus (EBV) receptor implantation onto human B lymphocytes changes immunoglobulin secretion patterns induced by EBV infection.
Tsukuda K; Volsky DJ; Shapiro IM; Klein G
Eur J Immunol; 1982 Jan; 12(1):87-90. PubMed ID: 6277643
[TBL] [Abstract][Full Text] [Related]
51. Immunologic cytotoxicity against autologous human lymphocytes transformed or infected by Epstein-Bar virus: role of antibody-dependent cellular cytotoxicity in health individuals.
Aya T; Mizuno F; Osato T
J Natl Cancer Inst; 1980 Aug; 65(2):265-71. PubMed ID: 6249949
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of polyclonal B-cell activation by suppressor monocytes in patients with sarcoidosis.
Katz P; Fauci AS
Clin Exp Immunol; 1978 Jun; 32(3):554-62. PubMed ID: 357055
[TBL] [Abstract][Full Text] [Related]
53. Systemic lupus erythematosus with deficiency of the T4 epitope on T helper/inducer cells.
Stohl W; Crow MK; Kunkel HG
N Engl J Med; 1985 Jun; 312(26):1671-8. PubMed ID: 2582253
[TBL] [Abstract][Full Text] [Related]
54. Phenotypic and functional analysis of EBV-specific memory CD8 cells in SLE.
Berner BR; Tary-Lehmann M; Yonkers NL; Askari AD; Lehmann PV; Anthony DD
Cell Immunol; 2005 May; 235(1):29-38. PubMed ID: 16181618
[TBL] [Abstract][Full Text] [Related]
55. Impairment of T-cell control of Epstein-Barr virus infected B-cells in patients with adult T-cell leukemia.
Katsuki T; Yamaguchi K; Matsuoka Y; Hinuma Y
AIDS Res; 1986 Dec; 2 Suppl 1():S125-30. PubMed ID: 3030343
[TBL] [Abstract][Full Text] [Related]
56. Suppressor T cell clones from patients with acute Epstein-Barr virus-induced infectious mononucleosis.
Wang F; Blaese RM; Zoon KC; Tosato G
J Clin Invest; 1987 Jan; 79(1):7-14. PubMed ID: 3025263
[TBL] [Abstract][Full Text] [Related]
57. Activation of human B lymphocytes. VIII. Differential radiosensitivity of subpopulations of lymphoid cells involved in the polyclonally-induced PFC responses of peripheral blood B lymphocytes.
Fauci AS; Pratt KR; Whalen G
Immunology; 1978 Nov; 35(5):715-20. PubMed ID: 363604
[TBL] [Abstract][Full Text] [Related]
58. Enhancement by TP-1, a thymic extract, of pokeweed mitogen-induced differentiation of B cells from normal subjects but not of those from patients with systemic lupus erythematosus.
Fiorilli M; Sirianni MC; Pandolfi F; Pucillo LP; Letta T; Aiuti F
Thymus; 1982 Jan; 4(1):1-7. PubMed ID: 6977207
[TBL] [Abstract][Full Text] [Related]
59. Cellular DNA content of T helper, T suppressor and B lymphocytes in SLE.
Surányi P; Mátyus L; Sonkoly I; Szegedi G
Clin Exp Immunol; 1984 Oct; 58(1):37-41. PubMed ID: 6236918
[TBL] [Abstract][Full Text] [Related]
60. Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus.
Bruns A; Bläss S; Hausdorf G; Burmester GR; Hiepe F
Arthritis Rheum; 2000 Oct; 43(10):2307-15. PubMed ID: 11037891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
